Diaz, D. D. J., Goldberg, A. D., Abella, S., Robb, C., Schelle, M., Crimmins, G. T. (2026). Phase 1, open-label, multi-center trial of RPT1G in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic syndromes/neoplasms.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps6601